Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
International Journal of Medicinal Mushrooms
Impact-faktor: 1.423 5-jähriger Impact-Faktor: 1.525 SJR: 0.431 SNIP: 0.716 CiteScore™: 2.6

ISSN Druckformat: 1521-9437
ISSN Online: 1940-4344

Volumes:
Volumen 22, 2020 Volumen 21, 2019 Volumen 20, 2018 Volumen 19, 2017 Volumen 18, 2016 Volumen 17, 2015 Volumen 16, 2014 Volumen 15, 2013 Volumen 14, 2012 Volumen 13, 2011 Volumen 12, 2010 Volumen 11, 2009 Volumen 10, 2008 Volumen 9, 2007 Volumen 8, 2006 Volumen 7, 2005 Volumen 6, 2004 Volumen 5, 2003 Volumen 4, 2002 Volumen 3, 2001 Volumen 2, 2000 Volumen 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v1.i2.30
pages 139-146

Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae)−A Mushrooming Medicinal Mushroom

Shu-Ting Chang
Department of Biology, Centre for International Services to Mushroom Biotechnology, The Chinese University of Hong Kong, Shatin, Hong Kong, China; and Department of Biological Sciences, University of Wollongong, Australia
John A. Buswell
Institute of Edible Fungi, Shanghai Academy of Agricultural Sciences, Shanghai 201106, China

ABSTRAKT

The medicinal properties of Ganoderma lucidum (Curt.: Fr.) P. Karst. have been recognized for many centuries in China and other parts of Asia. During the last two decades, there has been a sharp increase in the level of commercial interest in G. lucidum products, not only in Asian countries but also in North America and Europe. Latest available estimates put the annual value of G. lucidum products worldwide at more than US $1.6 billion. This increased demand has stimulated improvements in artificial cultivation methods, of which currently the most widely adopted are the wood log, short wood segment, tree stump, sawdust bag, and bottle procedures. The application of modern analytical techniques has revealed the mushroom to contain numerous bioactive compounds including polysaccharides, triterpenes, and immunomodulatory proteins. Many of these compounds have anticancer and antitumor properties that appear to be based on an enhancement of the host immune system rather than on a direct cytocidal effect. Further expansion of the market for G. lucidum products will require the introduction of more reproducible protocols for mushroom production and downstream processing to improve quality control and ensure enduring public trust.


Articles with similar content:

The Role of Culinary-Medicinal Mushrooms on Human Welfare with a Pyramid Model for Human Health
International Journal of Medicinal Mushrooms, Vol.14, 2012, issue 2
Solomon P. Wasser, Shu-Ting Chang
Recent Advances in Research of Pharmacology and Clinical Applications of Ganoderma P.Karst. Species (Aphyllophoromycetideae) in China
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 1
Geng Tao Liu
Medicinal Value of Turkey Tail Fungus Trametes versicolor (L.:Fr.) Pilat (Aphyllophoromycetideae)
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Christopher Hobbs
Cultivation of the Edible and Medicinal Mushroom Grifola frondosa (Dicks.:Fr.) S. F. Gray (Maitake)—Relevance of Literature to Production in Australia (Review)
International Journal of Medicinal Mushrooms, Vol.5, 2003, issue 2
Karen Stott
The World Mushroom Industry: Trends and Technological Development
International Journal of Medicinal Mushrooms, Vol.8, 2006, issue 4
Shu-Ting Chang